Taiwan-based bio-pharmaceutical firm JHL Biotech, Inc. has completed US$45.6 million series C round of financing led by an unnamed investor, ahead of the company's planned initial public offering, according to a company announcement. The lead investor is described as a global crossover fund with over US$1.6 trillion in assets-under-management. Existing investor Milestone Capital, as well […]


Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.


Visit the original source and full text: China Money Network